NEW YORK (GenomeWeb News) - Accelrys yesterday reported a half-a-percent decrease in fiscal first-quarter 2008 revenues as R&D spending was trimmed 15 percent and the company turned its quarterly loss to a profit.
 
Total receipts for the three months ended June 30, 2007, dipped to $20.1 million from $20.2 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.